Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Richard

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Clinical Pathology|August 1, 1974
An improved procedure for determining thromboplastin generationT Exner, K A Richard
Agents and Actions|January 1, 1993
The effects of several diphosphonates on murine bone marrow proliferationK A Richard, N D Staite
Thrombosis Research|August 1, 1975
The aggregation of fibrin powder suspensions by fibrinogen and its measurement by a sedimentation parameterT Exner, K A Richard, H Kronenberg
Journal of Biological Response Modifiers|December 1, 1987
Cytokines involved in the augmentation of murine natural killer cell activity by pyrimidinones in vivoK A Richard, R F Mortensen, D E Tracey
Prostaglandins|December 1, 1985
Production of prostaglandin D2 by murine macrophage cell linesJ C McGuire, K A Richard, F F Sun, et al.
Lymphokine Research|January 1, 1988
Resolution and biological properties of three N-terminal analogues of recombinant human interleukin-1 betaA W Yem, K A Richard, N D Staite, et al.
Immunopharmacology|January 1, 1988
Pharmacological inhibition of interleukin-1 activity on T cells by hydrocortisone, cyclosporine, prostaglandins, and cyclic nucleotidesD E Tracey, M M Hardee, K A Richard, et al.
Cancer Research|February 1, 1985
Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemiaL H Li, T L Wallace, K A Richard, et al.
Agents and Actions|June 1, 1989
Isolation and bioactivities of three IL-1 beta N-terminal variantsK A Richard, A W Yem, M R Deibel, et al.
Clinical Science (London, England : 1979)|March 1, 1989
Local pathological responses to slow-release recombinant interleukin-1, interleukin-2 and gamma-interferon in the mouse and their relevance to chronic inflammatory diseaseC J Dunn, M M Hardee, A J Gibbons, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Clinical Pathology|August 1, 1974
An improved procedure for determining thromboplastin generationT Exner, K A Richard
Agents and Actions|January 1, 1993
The effects of several diphosphonates on murine bone marrow proliferationK A Richard, N D Staite
Thrombosis Research|August 1, 1975
The aggregation of fibrin powder suspensions by fibrinogen and its measurement by a sedimentation parameterT Exner, K A Richard, H Kronenberg
Journal of Biological Response Modifiers|December 1, 1987
Cytokines involved in the augmentation of murine natural killer cell activity by pyrimidinones in vivoK A Richard, R F Mortensen, D E Tracey
Prostaglandins|December 1, 1985
Production of prostaglandin D2 by murine macrophage cell linesJ C McGuire, K A Richard, F F Sun, et al.
Lymphokine Research|January 1, 1988
Resolution and biological properties of three N-terminal analogues of recombinant human interleukin-1 betaA W Yem, K A Richard, N D Staite, et al.
Immunopharmacology|January 1, 1988
Pharmacological inhibition of interleukin-1 activity on T cells by hydrocortisone, cyclosporine, prostaglandins, and cyclic nucleotidesD E Tracey, M M Hardee, K A Richard, et al.
Cancer Research|February 1, 1985
Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemiaL H Li, T L Wallace, K A Richard, et al.
Agents and Actions|June 1, 1989
Isolation and bioactivities of three IL-1 beta N-terminal variantsK A Richard, A W Yem, M R Deibel, et al.
Clinical Science (London, England : 1979)|March 1, 1989
Local pathological responses to slow-release recombinant interleukin-1, interleukin-2 and gamma-interferon in the mouse and their relevance to chronic inflammatory diseaseC J Dunn, M M Hardee, A J Gibbons, et al.
Pageof 2